Completed PHASE4 INTERVENTIONAL 2-arm NCT02059460

Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney (Terli-NGAL)

Sponsor: Dr. Ayman Alsebaey Qotb Alghoraieb.

Conditions Acute Kidney Injury Liver Transplantation NGAL Terlipressin

Updated 5 times since 2017 Last updated: Dec 14, 2016 Started: May 31, 2013 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02059460, this PHASE4 trial focuses on Acute Kidney Injury and Liver Transplantation and remains completed. Sponsored by Dr. Ayman Alsebaey Qotb Alghoraieb., it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dr. Ayman Alsebaey Qotb Alghoraieb.
Dr. Khaled Ahmed Yassen
Dr. Khalid Mousa Abouelenain
Dr. Mohamed Abdelrauf kandil
Dr. Mohamed Helmi Ibrahim Afifi
National Liver Institute, Egypt

Data source: National Liver Institute, Egypt

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shebeen Alkom, Egypt